Publications
-
Gastrointestinal manifestations of Henoch-Schoenlein purpura.
Menon P,
Singh S, Ahuja N, Winter TA.
Dig Dis Sci.
2013;
58
(1):
42-5
-
A Moving Cause of Gastrointestinal Bleeding.
Wong RJ,
Winter TA.
Dig Dis Sci.
2012
-
Anti-inflammatories and the gastrointestinal tract: Victores et Victis.
Winter TA,
Quan SY.
J Gastroenterol Hepatol.
2012;
27
(5):
853-6
-
De novo arteriovenous malformations following implantation of the HeartMate II left ventricular assist device.
Huang RJ,
Wong RJ, Draper KV, Winter TA.
Endoscopy.
2012:
44 Suppl 2 UCTN
E441
-
Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: a cohort study.
Setshedi M,
Epstein D, Winter TA, Myer L, Watermeyer G, Hift R.
J Gastroenterol Hepatol.
2012;
27
(2):
385-9
-
Short bowel syndrome, gut failure and nutrition
Winter TA,
J Clin Trials.
2011:
1
e101
-
Colonic energy salvage in chronic pancreatic exocrine insufficiency.
Owira PM,
Winter TA.
JPEN J Parenter Enteral Nutr.
2008 Jan-Feb;
32
(1):
63-71
-
Omega-3 free fatty acids for the maintenance of remission in Crohn disease
Feagan BG,
Sandborn WJ, Mittman U, for the EPIC Randomized Controlled Trials.
JAMA.
2008:
299
1690-97
-
Effect of severe undernutrition and subsequent refeeding on gut mucosal protein fractional synthesis in human subjects.
Winter TA,
O'Keefe SJ, Callanan M, Marks T.
Nutrition.
2007;
23
(1):
29-35
-
Treatment of Crohn's disease with certolizumab pegol.
Winter TA,
Sandborn WJ, de Villiers WJ, Schreiber S.
Expert Rev Clin Immunol.
2007;
3
(5):
683-94
-
Certolizumab Pegol in Crohn's Disease - A Viewpoint (Editorial)
Winter, T.A.,
Certolizumab Pegol in Crohn's Disease - A Viewpoint (Editorial).
2007:
21
202-203
-
CDP870 in Crohn's disease: reconsidering endpoints.
Winter TA,
de Villiers WJ, Mardini HE.
Inflamm Bowel Dis.
2006;
12
(3):
249
-
Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial.
Schreiber S,
Feagan B, D'Haens G, Colombel JF, Geboes K, Yurcov M, Isakov V, Golovenko O, Bernstein CN, Ludwig D, Winter T, Meier U, Yong C, Steffgen J.
Clin Gastroenterol Hepatol.
2006;
4
(3):
325-34
-
The -237C-->T promoter polymorphism of the SLC11A1 gene is associated with a protective effect in relation to inflammatory bowel disease in the South African population.
Zaahl MG,
Winter TA, Warnich L, Kotze MJ.
Int J Colorectal Dis.
2006;
21
(5):
402-8
-
The effects of undernutrition and refeeding on metabolism and digestive function.
Winter TA,
Curr Opin Clin Nutr Metab Care.
2006;
9
(5):
596-602
-
The emerging role of mesenteric fat and its association with Crohn's disease
Arsenescu R,
de Villiers WJS, Winter TA.
Pract Gastroenterology.
2006:
29
43-46
-
The effect of severe undernutrition and subsequent refeeding on whole-body metabolism and protein synthesis in human subjects.
Winter TA,
O'Keefe SJ, Callanan M, Marks T.
JPEN J Parenter Enteral Nutr.
2005 Jul-Aug;
29
(4):
221-8
-
Analysis of the three common mutations in the CARD15 gene (R702W, G908R, and 1007fs) in South African colored patients with inflammatory bowel disease
Zaahl MG,
Winter T, Warnich L, Kotze MJ.
Molecular and Cellular Probes.
2005:
19
278-281
-
Comparison of inulin and lactulose as reference standards in the breath hydrogen test assessment of carbohydrate malabsorption in patients with chronic pancreatic exocrine insufficiency.
Owira PM,
Young GO, Winter TA.
Dig Dis Sci.
2005;
50
(6):
1058-63
-
Gastroduodenal Crohn's disease is associated with NOD2/CARD15 gene polymorphisms, particularly L1007P homozygosity.
Mardini HE,
Gregory KJ, Nasser M, Selby L, Arsenescu R, Winter TA, de Villiers WJ.
Dig Dis Sci.
2005;
50
(12):
2316-22
-
Natalizumab induction and maintenance therapy for Crohn's disease
Sandborn WJ,
Colombel JF, Enns R, Feagan BG, Hanauer SB, Lawrance IC, Panaccione R, Sanders M, Schreiber S, Targan S, van Deventer S, Goldblum R, Despain D, Hogge GS, Rutgeerts for the International Efficacy of Natalizumab as Active Crohn's Therapy (ENACT-1) Trial Groups and the Evaluation of Natalizumab as Continuous Therapy (ENACT-2) Trial Groups.
N Engl J Med.
2005:
353
1912-24
-
Feeding the patient who cannot eat
Winter TA,
S Afr J Clin Nutr.
2004:
17
70-73
-
Gastric and duodenal mucosal protein fractional synthesis and growth factor expression in patients with H. pylori-associated gastritis before and after eradication of the organism.
Winter TA,
Kidd M, Kaye P, Marks IN.
Dig Dis Sci.
2004;
49
(6):
925-30
-
Impaired gastric acid and pancreatic enzyme secretion in patients with Crohn's disease may be a consequenece of a poor nutritional state.
Winter TA,
O'keefe SJ, Callanan M, Marks T.
Inflamm Bowel Dis.
2004;
10
(5):
618-25
-
Intravenous CDP870, a PEGylated Fab' fragment of a humanized antitumour necrosis factor antibody, in patients with moderate-to-severe Crohn's disease: an exploratory study.
Winter TA,
Wright J, Ghosh S, Jahnsen J, Innes A, Round P.
Aliment Pharmacol Ther.
2004;
20
(11-12):
1337-46
-
Nutrition as primary and supportive therapy
Winter TA,
S Afr J Clin Nutr.
2004:
17
65-68
-
Budesonide and mesalamine in active Crohn's disease: a comparison of the effects on quality of life
Thomsen OO,
Cordot a, Jewell D, Wright JP, Winter T, Veloso FT, Vatn M, Persson T, Pettersson E.
Am J Gastroenterol.
2002:
97
649-653
-
Budesonide and mesalamine in active Crohn's disease: a comparison of the effects on quality of life
Thomsen OO,
Cordot a, Jewell D, Wright JP, Winter T, Veloso FT, Vatn M, Persson T, Pettersson E.
Am J Gastroenterol.
2002:
97
649-653
-
Investigation of HLA-DPA1 genotypes as predictors of inflammatory bowel disease in the German, South African, and South Korean populations.
Lantermann A,
Hampe J, Kim WH, Winter TA, Kidd M, Nagy M, Fölsch UR, Schreiber S.
Int J Colorectal Dis.
2002;
17
(4):
238-44
-
A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients
Ally R,
Schurman D, Keisel, et al and the Esophageal Candidiasis Study Group.
Clin Infect Dis.
2001:
33
1447-54
-
Cardiac consequences of malnutrition-Ancel keys revisited!
Winter TA,
Nutrition.
2001;
17
(5):
422-3
-
Impaired pancreatic secretion in severely malnourished patients is a consequence of primary pancreatic dysfunction.
Winter TA,
Marks T, Callanan M, O'Keefe SJ, Bridger S.
Nutrition.
2001;
17
(3):
230-5
-
Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease
Cordot A,
Colombel JF, Rutgeerts P, Lauritsen K, Malchow H, Hamling J, Winter T, Van Gossum A, Persson T, Pettersson E.
Gut.
2001:
48
186-190
-
Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease
Cordot A,
Colombel JF, Rutgeerts P, Lauritsen K, Malchow H, Hamling J, Winter T, Van Gossum A, Persson T, Pettersson E.
Gut.
2001:
48
186-190
-
The effect of severe undernutrition, and subsequent refeeding on digestive function in human patients.
Winter TA,
Lemmer ER, O'Keefe SJ, Ogden JM.
Eur J Gastroenterol Hepatol.
2000;
12
(2):
191-6
-
Alosetron relieves pain and improves bowel function compared with mebeverine in female non-constipated irritable bowel syndrome patients
Jones RH,
Holtmann G, Rodrigo L, et al and the International Alosetron Study Group.
Aliment Pharmacol Ther.
1999:
13
1419-27
-
Sucralfate and methylprednisolone enemas in active ulcerative colitis: a prospective, single-blind study.
Wright JP,
Winter TA, Candy S, Marks IS.
Dig Dis Sci.
1999;
44
(9):
1899-901
-
The influence of intravenous infusions of glucose and amino acids of pancreatic enzyme and mucosal protein synthesis in human subjects.
O'Keefe SJ,
Lemmer ER, Ogden JM, Winter T.
JPEN J Parenter Enteral Nutr.
1998 Sep-Oct;
22
(5):
253-8
-
Diabetic neuropathic cachexia: the importance of positive recognition and early nutritional support.
van Heel DA,
Levitt NS, Winter TA.
Int J Clin Pract.
1998 Nov-Dec;
52
(8):
591-2
-
A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.
Thomsen OO,
Cortot A, Jewell D, Wright JP, Winter T, Veloso FT, Vatn M, Persson T, Pettersson E.
N Engl J Med.
1998;
339
(6):
370-4
-
Basal and pentagastrin stimulated acid secretion in duodenal ulcer subjects before and after Helicobacter pylori eradication: a 12-month follow-up study.
Louw JA,
Young GO, Lucke W, Bridger S, Winter TA, Marks IN.
Ital J Gastroenterol Hepatol.
1998;
30
(4):
363-7
-
Effect of chronic duodenal ulceration and its treatment with lanzoprazole or sucralfate on gastroduodenal mucosal protein turnover and TGF-alpha, bFGF, and EGF receptor expression in humans.
Zhang T,
O'Keefe SJ, Winter T, Marks IN, Ogden J.
Dig Dis Sci.
1998;
43
(12):
2764-70
-
Sucralfate enemas in ulcerative colitis.
Winter TA,
Marks IN.
Aliment Pharmacol Ther.
1997;
11
(4):
821-2
-
Management of inflammatory bowel disease--an alternative approach?
Winter TA,
S Afr Med J.
1996;
86
(10 Suppl):
1335-6
-
Small bowel intussusception and brown bowel syndrome in association with severe malnutrition.
Drake WM,
Winter TA, Price SK, O'Keefe SJ.
Am J Gastroenterol.
1996;
91
(7):
1450-2
-
Effect of sucralfate on Helicobacter pylori and severity of gastritis in patients with duodenal ulcer.
Winter TA,
Louw JA, Marks IN, Jaskiewicz K, Lucke W, Callanan M.
Scand J Gastroenterol Suppl.
1995:
210
85-8
-
Helicobacter pylori eradication in the African setting, with special reference to reinfection and duodenal ulcer recurrence.
Louw JA,
Lucke W, Jaskiewicz K, Lastovica AJ, Winter TA, Marks IN.
Gut.
1995;
36
(4):
544-7
-
Severe hypophosphataemia in anorexia nervosa.
Cariem AK,
Lemmer ER, Adams MG, Winter TA, O'Keefe SJ.
Postgrad Med J.
1994;
70
(829):
825-7
-
Cyclosporin A retention enemas in refractory distal ulcerative colitis and 'pouchitis'.
Winter TA,
Dalton HR, Merrett MN, Campbell A, Jewell DP.
Scand J Gastroenterol.
1993;
28
(8):
701-4
-
Triple therapy with sucralfate is as effective as triple therapy containing bismuth in eradicating Helicobacter pylori, and reducing duodenal ulcer relapse rates
Louw JA,
Zak J, Lucke W, Le Roux E, Jaskiewicz K, Winter T, Lastovica A, Marks IN.
Scand J Gastroenterol.
1992:
27
28-31
-
An assessment of registrars and their training programmes at the University of Cape Town Teaching Hospitals.
Winter TA,
Painter ML, Slack M.
S Afr Med J.
1990;
77
(6):
304-6
-
Registrar training
Winter TA,
Painter M, Slack M.
S Afr Med J.
1990:
78
110
-
Omeprazole and ranitidine in duodenal ulcer healing.
Marks IN,
Winter TA, Lucke W, Wright JP, Newton KA, O'Keefe SJ, Marotta F.
S Afr Med J.
1988:
74 Suppl
54-6
-
Severe malnutrition associated with alpha-heavy chain disease: response to tetracycline and intensive nutritional support.
O'Keefe SJ,
Winter TA, Newton KA, Ogden JM, Young GO, Price SK.
Am J Gastroenterol.
1988;
83
(9):
995-1001
Navigation for This Section: Department of Medicine
Find a Researcher
Help